MMP9 and neoplasm: MicroRNA-128 alleviated SSR-enhanced HeLa and CaSki cells’ adhesion and metastasis through suppressing numerous molecules, including ITGA5, ITGA5, sLex, CEACAM-6, MMP9, and MMP23. The evidence indicates that the nucleoid-based miR-128 strategy may be an attractive therapeutic strategy against tumor cells resistant to the shear flow of blood circulation and to prevent vascular adhesion and subsequent cervical cancer cell migration.